Senior insider sale
EVP & Chief Scientific Officer at INCYTE CORP — senior position signals high conviction
$6.01M
50.16K shares
What this filing means
MAYES PATRICK A plans to sell 50.16K shares of INCYTE CORP valued at approximately $6.01M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/5/2026ACC: 0001950047-26-007673
Officer· EVP & Chief Scientific Officer
Since Jul 2025
50.16K
Shares to sell
$6.01M
Approx. market value
2.21K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
8/5/2026
2.21KTotal acquired2.21K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/5/2026 | Stock Option Exercise Cash | 2.21K | — |
| Total | 2.21K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
6.05K
Market value
$729.2K
8/3/2026
—Completed
Units to sell
41.90K
Market value
$5.01M
7/31/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.21K
Market value
$273.6K
8/5/2026
Total
Units
50.16K
Value
$6.01M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/3/2026 | 6.05K | $729.2K | — | Completed |
7/31/2026 | 41.90K | $5.01M | — | Completed |
| Planned — Approximate Date | ||||
8/5/2026 | 2.21K | $273.6K | NASDAQ | Planned |
| Total | 50.16K | $6.01M | ||